Johnson & Johnson
New Brunswick, NJ 08933
Share:
ACUVUE Celebrates 20th Anniversary of First Disposable Contact Lens With Launch of New 1-DAY ACUVUE® MOIST(TM)
Unique LACREON(TM) technology keeps lens moist and comfortable all day; Offers benefits for eye allergy sufferers JACKSONVILLE, Fla., March 22 / -- Twenty years after revolutionizing the contact lens industry with the introduction of the first disposable soft contact lens, VISTAKON(R), Division of Johnson & Johnson Vision Care, Inc., today announced the U.S. launch of 1-DAY ACUVUE(R) MOIST(TM)...
Read More »Johnson & Johnson and Synthes Announce Definitive Merger Agreement to Create World's Most Innovative and Comprehensive Orthopaedics Business
Transaction Valued at $21.3 Billion, Based on CHF 159.0 Per Share NEW BRUNSWICK, N.J. and WEST CHESTER, Pa., April 27, 2011 - Johnson & Johnson (NYSE: JNJ), the world's most comprehensive and broadly-based manufacturer of health care products, and Synthes, Inc. (SWX:SYST.VX), a premier global manufacturer of orthopaedic devices, today announced that they have entered into a definitive agreement...
Read More »Minimum Acceptance Condition Satisfied
NEW BRUNSWICK, N.J., and LEIDEN, Netherlands, Feb. 17, 2011 - Johnson & Johnson (NYSE: JNJ) and Crucell N.V. (NYSE Euronext, Nasdaq: CRXL; Swiss Exchange: CRX) today announced that the minimum acceptance condition of Johnson & Johnson's Offer to acquire Crucell N.V. (Crucell) has been satisfied. The initial offering period of the Offer expired at 17:45 hours Dutch time (11:45 a.m. New York time)...
Read More »Johnson & Johnson Receives Approval from European Commission
NEW BRUNSWICK, N.J. and LEIDEN, Netherlands, Jan. 28, 2011 - Johnson & Johnson and Crucell today announced that the European Commission has granted approval for Johnson & Johnson's proposed acquisition of Crucell. Reference is made to the joint press release of Johnson & Johnson (NYSE: JNJ) and Crucell N.V. (NYSE Euronext, Nasdaq: CRXL; Swiss Exchange: CRX) dated 8 December 2010 announcing the...
Read More »Johnson & Johnson Completes Acquisition of Micrus Endovascular
Micrus Becomes Part of Codman Neurovascular NEW BRUNSWICK, N.J., Sept. 27 - Johnson & Johnson (NYSE: JNJ) today announced that it has completed the acquisition of Micrus Endovascular, a global developer and manufacturer of minimally invasive devices for hemorrhagic and ischemic stroke. Johnson & Johnson announced its agreement to acquire Micrus on July 12, 2010. Micrus Endovascular will operate...
Read More »Johnson & Johnson to Participate in the 28th Annual Cowen & Company Health Care Conference
NEW BRUNSWICK, N.J., March 13 -- Johnson & Johnson will participate in the 28th Annual Cowen & Company Health Care Conference on Thursday, March 20th at the Boston Marriott Copley Place Hotel in Boston, Massachusetts. Colleen Goggins, Worldwide Chairman, Consumer Group will represent the Company in a session scheduled at 11:00 a.m. (Eastern Time). The webcast will be available to investors and...
Read More »Johnson & Johnson to Participate in Lehman Brothers Eleventh Annual Global Healthcare Conference
NEW BRUNSWICK, N.J., March 11 -- Johnson & Johnson will participate in the Eleventh Annual Lehman Brothers Global Healthcare Conference on Tuesday, March 18th at the Loews Miami Beach Hotel in Miami, Florida. Dominic Caruso, Vice President, Finance and Chief Financial Officer, will represent the Company in a session scheduled at 11:15 a.m. (Eastern Time). The webcast will be available to...
Read More »Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Breaks Ground on New Facility
SPRING HOUSE, Pa., April 19 -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) announced today it has started construction of a new building on its Spring House, Pennsylvania campus, that will add approximately 150,000 square feet in new laboratory, clinical development and office space to its existing facilities. The site will become J&JPRD's East Coast hub for discovery...
Read More »ACUVUE Celebrates 20th Anniversary of First Disposable Contact Lens With Launch of New 1-DAY ACUVUE® MOIST(TM)
Unique LACREON(TM) technology keeps lens moist and comfortable all day; Offers benefits for eye allergy sufferers JACKSONVILLE, Fla., March 22 / -- Twenty years after revolutionizing the contact lens industry with the introduction of the first disposable soft contact lens, VISTAKON(R), Division of Johnson & Johnson Vision Care, Inc., today announced the U.S. launch of 1-DAY ACUVUE(R) MOIST(TM)...
Read More »Johnson & Johnson Completes Acquisition of Conor Medsystems, Inc.
NEW BRUNSWICK, N.J., Feb. 1 -- Johnson & Johnson (NYSE:JNJ) today announced the closing of its previously announced acquisition of Conor Medsystems, Inc., a cardiovascular device company with a unique controlled drug delivery technology. The completion of the acquisition of Conor Medsystems adds an important platform to our capacity to address cardiovascular and vascular disease globally, said...
Read More »